Share

October 2021; 11 (5) Review

Practical Considerations for Ketogenic Diet in Adults With Super-Refractory Status Epilepticus

Neha Kaul, Joshua Laing, John-Paul Nicolo, Judy Nation, Patrick Kwan, Terence J. O'Brien
First published October 30, 2020, DOI: https://doi.org/10.1212/CPJ.0000000000001009
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
339

Share

Article Information

vol. 11 no. 5 438-444
DOI: 
https://doi.org/10.1212/CPJ.0000000000001009
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received May 31, 2020
  • Accepted October 5, 2020
  • First Published October 30, 2020.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Neha Kaul, BNutrDiet(Hons), APD,
    2. Joshua Laing, MBBS, FRACP,
    3. John-Paul Nicolo, MBBS, FRACP,
    4. Judy Nation, MND, AdvAPD,
    5. Patrick Kwan, PhD, FRACP and
    6. Terence J. O'Brien, MD, FRACP
  1. Neha Kaul, BNutrDiet(Hons), APD,
    2. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Health and Medical Research Council, APP1133304, Dora Lush Biomedical Postgraduate Research Scholarship, 2017-2019

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Joshua Laing, MBBS, FRACP,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Epilepsy Society of Australia travel grant

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) UCB

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NHMRC PhD Scholarship, APP1169386, 2019-2021

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Brain Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. John-Paul Nicolo, MBBS, FRACP,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Australian Government Research Training Program Scholarship 2017-2020

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Judy Nation, MND, AdvAPD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Patrick Kwan, PhD, FRACP and
    6. Scientific Advisory Boards:

    1. Eisai, UCB Pharma

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. UCB Pharma, Eisai, LivaNova

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. He/his institution also received speaker or consultancy fees and/or research grants from Biscayne, Eisai, GW Pharmaceuticals, LivaNova, Novartis, UCB Pharma and Zynerba. He is supported by the Medical Research Future Fund Practitioner Fellowship.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Eisai, UCB Pharma

    Research Support, Government Entities:

    1. (1) Australian National Health & Medical Research Council (APP1103979), PI, 2016-2018; (2) Australian National Health & Medical Research Council (APP1136427), PI, 2018 – 2021; (3) Australian National Health & Medical Research Council (APP1143934), PI, 2018 – 2021; (4) National Science Foundation of China (81728006), PI, 2018 – 2019; (5) Medical Future Research Fund Practitioner Fellowship (MRF1136427), PI, 2018-2022.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Terence J. O'Brien, MD, FRACP
    7. Scientific Advisory Boards:

    1. Medical Advisory Board, Eisai Medical Advisory Board, UCB Medical Advisory Board, LivaNova Medical Advisory Board, Supernus Medical Advisory Board, LivaNova

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) UCB Pharma, speaker honoraria; (2) Eisai, speaker honoraria

    Editorial Boards:

    1. (1) Epilepsy and Behavior (2009-17), 2), British Journal of Clinical Pharmacology (2011-17), 3) Epilepsia Open (2016-17), 4) Epilepsia

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Zynerba pharmaceuticals - medical monitor

    Speakers' Bureaus:

    1. Speaker fees for Eisai, UCB

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) UCB; (2) Zynerba; (3) Sanofi, (4)Janssen- Cilag; (5) Eisai

    Research Support, Government Entities:

    1. NHMRC Project grants (Australia) 2006-18; NHMRC Centre for Research Excellence Grant (2011-16), NIH (2016-17), NHMRC Program Grant 2016-20. NHMRC Investigator Grant 2019

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. RMH Neuroscience Foundation 2008-18

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Allied Health (Clinical Nutrition) (NK), Royal Melbourne Hospital; Department of Nutrition and Dietetics, (NK) Alfred Hospital; Departments of Medicine and Neurology (NK, J-PN, JN, PK, TJO), Royal Melbourne Hospital, University of Melbourne; and Departments of Neurosciences and Neurology (NK, JL, J-PN, PK, TJO), Alfred Hospital and Monash University, Melbourne, Australia.
  1. Correspondence
    Ms. Kaul n.kaul{at}alfred.org.au

Article usage

Article usage: October 2020 to October 2023

AbstractFullPdfSource
Oct 20203802Highwire
Nov 2020430018Highwire
Dec 2020116016Highwire
Jan 2021105023Highwire
Feb 2021144033Highwire
Mar 2021342011Highwire
Apr 2021152021Highwire
May 202111203Highwire
Jun 20217507Highwire
Jul 20215606Highwire
Aug 2021142028Highwire
Sep 20219306Highwire
Oct 20212383325Highwire
Nov 20212221116Highwire
Dec 2021282714Highwire
Jan 20221391310Highwire
Feb 202213778Highwire
Mar 2022147915Highwire
Apr 202211535Highwire
May 202213503Highwire
Jun 20229945Highwire
Jul 202214199Highwire
Aug 202218679Highwire
Sep 202214523Highwire
Oct 2022134106Highwire
Nov 202217286Highwire
Dec 20229222Highwire
Jan 202318885Highwire
Feb 202397146Highwire
Mar 2023125128Highwire
Apr 20237631Highwire
May 20238110Highwire
Jun 20238310Highwire
Jul 20238731Highwire
Aug 20239236Highwire
Sep 20237921Highwire
Oct 202310541Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me